Experimental colitis impairs linear bone growth independent of nutritional factors

Journal of Pediatric Gastroenterology and Nutrition

Volumn 25, Issue 2, 1997, Pages 137-141

  Koniaris, Soula G ^a   Fisher, Stanley E ^a   Rubin, Clinton T ^b   Chawla, Anupama ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Bone growth; Colitis; Interleukin 6; Rats; Trinitrobenzene sulfonic acid

Indexed keywords

INTERLEUKIN 6; TRINITROBENZENESULFONIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE GROWTH; CARTILAGE CELL; CHILDHOOD DISEASE; CHRONIC DISEASE; COLITIS; CONTROLLED STUDY; ENTERITIS; GROWTH DISORDER; HISTOLOGY; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL NUTRITION PHYSIOLOGY; ANIMALS; BIOLOGICAL ASSAY; BONE DEVELOPMENT; CALCIUM; COLITIS; COLON; DISEASE MODELS, ANIMAL; GROWTH PLATE; INTERLEUKIN-6; MAGNESIUM; MALE; RATS; RATS, SPRAGUE-DAWLEY; TIBIA; TIME FACTORS; WEIGHT GAIN; ZINC;

ANIMALIA;

EID: 0030873039     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199708000-00002     Document Type: Article

References (45)

1. Markowitz JF, Grancher K, Rosa J, Aiges H, Daum F. Growth failure in pediatric inflammatory bowel disease. Journal of Pediatr Gastroenterol and Nutr 1993;16:373-80.
2. Sartor RB. Pathogenetic and clinical relevance of cytokines in inflammatory bowel disease. Immunol Res 1991;10:465-71.
3. Dinarello CA. Interleukin 1. Dig Dis Sci 1988;33(suppl):25S-35S.
4. Old LJ. Tumor Necrosis Factor. Science 1985;230:630-2.
5. Liqumsky M, Simon PL, Karmeli F, Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut 1990;31:686-9.
6. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 1989;30:835-8.
7. Isaacs KL, Sartor RB, Haskill S. Cytokine mRNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992;103:1587-95.
8. Mac-Donald TT, Hutchings P, Choy MY, et al. Tumor necrosis factor-alpha and interferon-gamma production measured at the single-cell level in normal and inflamed human intestine. Clin Exp Immunol 1990;81:301-5.
9. Mitsuyama K, Sada M, Ikeda H, et al: Serum Levels of interleukin-6 in patients with inflammatory bowel disease. Nippon Shokakibyo Gakkai Zasshi 1990;87:890.
10. Murch SH, Lamkin VA, Savage MD, Walker-Smith JA, MacDonald TT. Serum concentrations of tumor necrosis factor-alpha in childhood chronic inflammatory bowel disease. Gut 1991;32:913-17.
11. Lorenzo JA, Sousa SL, Alander C, Raisz LG, Dinarello CA. Comparison of the bone resorbing activity in the supernatants from phytohemaglutinin-stimulated human peripheral blood mononuclear cells with that of cytokines through the use of an antiserum to interleukin-1. Endocrinology 1987;121:1164-70.
12. Gowen MD, Wood SD, Ihrie EJ, McGuire MKB, Russell RGR. An interleukin-1 like factor stimulates bone resorption in vitro. Nature 1983;306:378-80.
13. Heath JK, Saklatula J, Meikle MC, Atkinson SJ, Reynolds JJ. Interleukin 1 (catabolin) is a potent stimulator of bone resorption in vivo. Tissue Int 1985;37:95-7.
14. Ishimi, Y., Miyaura C., Jin CH., et al. Interleukin-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990;145(10): 3297-303.
15. Hyams JS, Treem WR, Eddy E, Wyzga N, Moore RE. Tumor necrosis factor-alpha is not elevated in children with IBD. J Pediatr Gastroenterol Nutr 1991;12:233-6.
16. Morris GP, Beck PL, Herridge MS, Depew WT, Szewcank MR, Wallace JL. Hapten induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803.
17. Duffy LF, Karl PI, Daum F, Fisher SE. Hepatic Na, K-ATPase development in the rat. J Pediatr Gastroenterol Nutr 1988;7:894-901.
18. Wallace JL, MacNaughton WK, Morris GP, Beck PL. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 1989;96:29-36.
19. Hunziker EB, Schenk RK, Cruz-Orive LM. Quantitation of chondrocyte performance in growth plate cartilage during longitudinal hone growth. J of Bone Joint Surg 1987;69:162-73.
20. Trudeau KL, Freier EF. Determination of calcium in urine and serum by atomic absorption spectrophotometry (AAS). Clin Chem 1967;13:101-14.
21. Wapnir RA, Stiel L, Lee SY. Zinc intestinal absorption: effect of carbohydrates. Nutr Res 1989;9:1277-84.
22. Aarden, LA, Degroot, ER, Schaap, OL, and Landsorp, PJ: Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987;17:1411-16.
23. Van Snick J, Cayphas A, Vink A, Vytienhoe C., Coulie M, Rubira R, and Simpson RJ: Purification and NH2-terminal amino acid sequence of a T-cell derived lymphokine with growth factor activity for B-cell hybridomas. Proc Nat Aca Sci 1986;83:9679-83.
24. Fries W, Giacomin D, Plebani M, Martin A. Effect of experimental colitis on bone metabolism is the rat. Digestion 1994;55:229-33.
25. Van Snick J. Interleukin-6: an overview. Ann Rev Immunol 1990; 8:253-78.
26. Stevens C, Walz G, Singaram C, et al. Tumor necrosis factor-α, interleukin-1β and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992;37:818-26.
27. Mahida YR, Kurlac L, Gallagher A, Hawkey CJ. High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut 1991;32:1531-4.
28. Mitsuyama K, Sasaki E, Toyonaga A, et al. Colonie mucosal IL-6 in inflammatory bowel disease. Digestion 1991;50:104-11.
29. Mitsuyama K, Sata M, Tanikuwa K. Significance of IL-6 in patients with inflammatory bowel disease. Gastroenterol Jpn 1991;26:20-8.
30. Gross V, Andus T, Caesar I, Roth M, Scholmerich J. Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology 1992;102:514-18.
31. Mitsuyama K, Toyanaga A, Sasaki A, Ishida O, Ikeda H, et al. Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6. Gut 1995;36:45-9.
32. Reinecker HC, Steffen M, Witthoeft T, et al. Enhanced secretion of tumor necrosis factor-alpha. IL-6 and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993;94:174-81.
33. Neilly PJD, Gardiner KR, Kirk SJ, et al. Endotoxaemia and cytokine production in experimental colitis. Brit J Surg 1995;82:1479-82.
34. Li YP, Stashenko P. Proinflammatory cytokines TNF-α, and IL-6 but not IL-1 down-regulate the osteocalcin gene promoter. J Immunol 1992;148:788-94.
35. Hauschka, P., Lian, J, Gallop, P. Direct identification of the calcium binding amino acid gamma-carboxyglutamate in mineralized tissue. Proc Natl Acad Sci 1975;72:3925.
36. Lian, J., Gundberg, C.A. Osteocalcin: biomedical considerations and clinical applications. Clin Orthop Rel Res 1988;226:267.
37. Fang MA, Hahn TJ. Effects of Interleukin-6 on cellular function in UMR-106-01 osteoblastic cells. J Bone Miner Res 1991;6:133-9.
38. Ishimi Y, Miyaura C, Hejin C, et al. Interleukin-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990;145: 3297-303.
39. Kurihara N, Bertolini D, Suda T, Akiyama Y, Roodman GD. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol 1990;144:4226-230.
40. Thomson BM, Mundy GR, Chambers TJ. Tumor necrosis factors α and β induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 1987;138:775-9.
41. Gowen M, Mundy GR. Actions of recombinant IL-1, IL-2 and interferon-γ on bone resorption in vitro. J Immunol 1986;136;2478-82.
42. Konig A, Muhlbauer RC, Fleisch H. Tumor necrosis factor α and interleukin-1 stimulate bone resorption in vivo as measured by urinary [3H]-tetracycline excretion from pre-labelled mice. J of Bone Miner Res 1988;3:621-27.
43. Gardiner KR, Halliday MI, Barclay JR, et al. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 1995;36:897-901.
44. Mack DR, Lau AS, Sherman PM. Systemic tumor necrosis factor-alpha production in experimental colitis. Dig Dis Sci 1992;37: 1738-45.
45. Rachmilewitz DR, Simon PL, Schwartz LW, et al. Inflammatory mediators of experimental colitis in rats. Gastroenterology 1989; 97:326-37.